DB
CVS icon

Dmitry Balyasny’s CVS Health CVS Stock Holding History

Dmitry Balyasny’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.9M Buy
182,900
+129,100
+240% +$11.5M 0.02% 745
2026
Q1 		$3.86M Sell
53,800
-27,800
-34% -$2.14M 0.01% 1475
2025
Q4 		$6.48M Sell
81,600
-260,700
-76% -$20.6M 0.01% 1261
2025
Q3 		$25.8M Buy
342,300
+248,000
+263% +$17M 0.03% 604
2025
Q2 		$6.5M Buy
94,300
+59,900
+174% +$3.93M 0.01% 1168
2025
Q1 		$2.33M Sell
34,400
-23,600
-41% -$1.41M ﹤0.01% 1634
2024
Q4 		$2.6M Buy
58,000
+8,900
+18% +$499K ﹤0.01% 1574
2024
Q3 		$3.09M Hold
49,100
– – 0.01% 1484
2024
Q2 		$2.9M Buy
+49,100
New +$3.07M 0.01% 1398
2024
Q1 		– Sell
-100,000
Closed -$7.9M – 2713
2023
Q4 		$7.9M Buy
+100,000
New +$7.12M 0.01% 945
2023
Q1 		– Sell
-10,000
Closed -$932K – 2741
2022
Q4 		$932K Buy
+10,000
New +$965K ﹤0.01% 1688
2021
Q3 		– Sell
-8,900
Closed -$743K – 2018
2021
Q2 		$743K Buy
+8,900
New +$729K ﹤0.01% 1426

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Dmitry Balyasny's CVS Position: Q2 2026 in Review

Dmitry Balyasny reduced its CVS Health (CVS) stake by 81% in Q2 2026, selling an estimated $85.9M and leaving 228,956 shares worth $23.7M. The position accounts for 0.03% of the portfolio, ranked #640.

Dmitry Balyasny first reported a position in CVS in Q4 2013 and has held it in 40 quarters since. The position peaked at $98.1M in Q2 2025. 2,059 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Dmitry Balyasny held 228,956 shares of CVS Health worth $23.7M as of Q2 2026.
  • Dmitry Balyasny sold 962,067 CVS Health shares in Q2 2026, an estimated $85.9M.
  • CVS Health made up 0.03% of Dmitry Balyasny's portfolio in Q2 2026, its #640 holding.
  • Dmitry Balyasny first reported a position in CVS Health in Q4 2013 and has held it in 40 quarters since.
  • Dmitry Balyasny's CVS Health position peaked at $98.1M in Q2 2025.
  • 2,059 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.